Xilio Therapeutics, Inc.
XLO
$8.95
$0.040.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.92% | 68.78% | 148.74% | 69.39% | 62.18% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.34% | 82.13% | -49.50% | 37.80% | -29.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.58% | 65.46% | 140.77% | 96.01% | 58.59% |
|
|
|||||
| Total Current Assets | 17.58% | 65.46% | 140.77% | 96.01% | 58.59% |
| Net Property, Plant & Equipment | -16.09% | -14.45% | -13.33% | -18.49% | -17.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.39% | 1.40% | 1.40% | 1.46% | -3.60% |
| Total Assets | 15.28% | 57.63% | 117.64% | 79.08% | 48.89% |
|
|
|||||
| Total Accounts Payable | -43.50% | -53.23% | 23.08% | 136.63% | 224.13% |
| Total Accrued Expenses | 39.73% | 131.01% | 17.61% | -8.59% | -42.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.82% | 12.89% | 13.05% | 13.11% | 12.56% |
| Total Finance Division Other Current Liabilities | -46.54% | -21.64% | 196.07% | 67.96% | 59.44% |
| Total Other Current Liabilities | -46.54% | -21.64% | 196.07% | 67.96% | 59.44% |
| Total Current Liabilities | -35.79% | -9.82% | 106.42% | 48.34% | 37.83% |
|
|
|||||
| Total Current Liabilities | -35.79% | -9.82% | 106.42% | 48.34% | 37.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.61% | -20.85% | -19.31% | -17.94% | -16.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -36.12% | 10.29% | 198.66% | 845.68% | 555.43% |
| Total Liabilities | -35.31% | -2.23% | 123.30% | 164.12% | 124.50% |
|
|
|||||
| Common Stock & APIC | 20.72% | 22.85% | 13.13% | 7.51% | 7.66% |
| Retained Earnings | -5.29% | -7.88% | -9.13% | -15.78% | -15.76% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 922.27% | 577.99% | 100.44% | -138.60% | -78.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 922.27% | 577.99% | 100.44% | -138.60% | -78.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 922.27% | 577.99% | 100.44% | -138.60% | -78.85% |
|
|
|||||